New insights on the use of desipramine as an inhibitor for acid ceramidase (Q40244998)

18 September 2017

title

New insights on the use of desipramine as an inhibitor for acid ceramidase (English)

1 reference

18 September 2017

10

Yusuf A Hannun

1 reference

18 September 2017

Saeed Elojeimy

1

1 reference

18 September 2017

David H Holman

2

1 reference

18 September 2017

Xiang Liu

3

1 reference

18 September 2017

Ahmed El-Zawahry

4

1 reference

18 September 2017

Maristella Villani

5

1 reference

18 September 2017

Joseph C Cheng

6

1 reference

18 September 2017

Ayman Mahdy

7

1 reference

18 September 2017

Youssef Zeidan

8

1 reference

18 September 2017

Alicja Bielwaska

9

1 reference

18 September 2017

James S Norris

11

1 reference

18 September 2017

language of work or name

English

0 references

publication date

4 August 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

580

1 reference

18 September 2017

issue

19

1 reference

18 September 2017

page(s)

4751-4756

1 reference

Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Biologically active sphingolipids in cancer pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Cell line dependent involvement of ceramide in ultraviolet light-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Ceramide signaling in fenretinide-induced endothelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Purification, characterization, and biosynthesis of human acid ceramidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Quantitative measurement of different ceramide species from crude cellular extracts by normal-phase high-performance liquid chromatography coupled to atmospheric pressure ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Acid ceramidase but not acid sphingomyelinase is required for tumor necrosis factor-{alpha}-induced PGE2 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Chloroquine-mediated radiosensitization is due to the destabilization of the lysosomal membrane and subsequent induction of cell death by necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Human acid ceramidase is overexpressed but not mutated in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

10.1016/J.FEBSLET.2006.07.071

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference